TUMORMARKERSㅣTHYROIDㅣFERTILITYㅣENDOCRINOLOGYㅣDIABETESㅣANEMIAㅣPHOSPHOCALCIC AXISㅣCARDIAC MARKERSㅣHEPATITISㅣOTHERS
 

PRODUCT

REF.
(No of tubes)

METHOD
SEPARATION

TRACER
ACT (kBq)

STANDARD
(No and Range)

CONTROLS

SAMPLE
(Vol. and type)

INCUBATIONS
(Time/T°)

SHELF-LIFE
(Labelling
periodicity)

COMMENTS

ANTI-ACETYL CHOLINE RECEPTOR AUTO-ANTIBODIES

ACHR-AB
(25)

RRA
RadioReceptor Assay

¹²⁵ I
55

2
NEG, POS

0

5μl
(or 50μl diluted)
Serum

2 h / RT
+ 2 h / 4°C or
20 h / 4°C

6 weeks
(every 4 weeks)

Diagnostic tool
in myasthenia gravis

GASTRIN

GASK-PR
(100)

RIA Competition
precipitating reagent

¹²⁵ I
37

6
0 → 1500μU/ml

0

100μl
Serum, Plasma

2 h + 15'
RT

4 weeks
(every 4 weeks)

PIIIP

OCFK07PIIIP
(100)

IRMA
Coated tubes

¹²⁵ I
300

7
0 → 14U/ml

1

20μl
Serum, Plasma

2 h + 3 h
RT

6 weeks
(every 4 weeks)

Monoclonal antibodies

TRYPSIN

OCFE07-TRYPS
(100)

RIA Competition
precipitating reagent

¹²⁵ I
90

7
0 → 1200 ng/ml

1

100μl
Serum

3 h + 30'
RT

7 weeks
(every 4 weeks)

TRYPSIN Neonatal

OCML07TRNO
(250)

RIA Competition
precipitating reagent

¹²⁵ I
250

6
0 → 2500ng/ml

1

whole blood
4.25 mm disk

17 h + 2 h + 15'
RT

7 weeks
(every 4 weeks)

 Cystic fibrosis screening